Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118679542 | 11867954 | 2 | F | 20160701 | 20151224 | 20160725 | PER | US-009507513-1512USA007452 | MERCK | 33.00 | YR | F | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118679542 | 11867954 | 1 | PS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | DAILY DOSE 800 DF | 22145 | TABLET | |||||||||
| 118679542 | 11867954 | 2 | SS | ATAZANAVIR | ATAZANAVIR | 1 | Oral | DAILY DOSE 400 DF | 0 | ||||||||||
| 118679542 | 11867954 | 3 | SS | DARUNAVIR | DARUNAVIR | 1 | DAILY DOSE 800 DF | 0 | |||||||||||
| 118679542 | 11867954 | 4 | SS | RITONAVIR. | RITONAVIR | 1 | DAILY DOSE 100 DF | 0 | |||||||||||
| 118679542 | 11867954 | 5 | SS | emtricitabine (+) tenofovir disoproxil fumarate | EMTRICITABINETENOFOVIR DISOPROXIL | 1 | Oral | DAILY DOSE 1 DF | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118679542 | 11867954 | Exposure during pregnancy | |
| 118679542 | 11867954 | No adverse event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |